Basic info
Industry
biotechnology research
Sectors
Biotechnology
Health Care
Medical
Pharmaceutical
Date founded
2015
Funding rounds raised
Total raised
$50M
from 8 investors over 8 rounds
E
Entasis Therapeutics raised $3.8M on October 12, 2017
Investors: CARB-X
E
Entasis Therapeutics raised $32M on September 5, 2017
Investors: Sofinnova Ventures, Russia technology fund and TPG Global
E
Entasis Therapeutics raised $6.3M on March 31, 2017
Investors: CARB-X
E
Entasis Therapeutics raised $50M on April 4, 2016
Investors: Novo Holdings, Eventide Asset Management, Clarus Ventures, LLC and Frazier Healthcare Partners